Dr. Delgado is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Ste 3039
Miami, FL 33136Phone+1 305-243-4951Fax+1 305-243-7432
Summary
- Dr. Silvia Delgado is a neurologist at the Department of Neurology, University of Miami, School of Medicine, in Florida and she is affiliated with several hospitals in the area, including University of Miami Hospital, Jackson Health System, and University of Miami Hospital and Clinics. She received her medical degree from Instituto Superior de Ciencias Médicas de La Habana In 1985. She speaks Spanish fluently. She specializes in neuroimmunology/multiple sclerosis and is experienced in multiple sclerosis and related disorders including neuromyelitis optica and also in clinical research in this field.
Education & Training
- University of Miami/Jackson Health SystemResidency, Neurology, 1998 - 2001
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1997 - 1998
- Instituto Superior de Ciencias Médicas de la HabanaClass of 1985
Certifications & Licensure
- FL State Medical License 2001 - 2027
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Person-Centered Social Determinants and Neighborhood-Level Deprivation Associated With Disability in Hispanic People With Multiple Sclerosis.Lilyana Amezcua, Carlos Cardenas-Iniguez, Christopher Orlando, Andrea Martinez, Iffat Nahar
Neurology. 2025-02-11 - 1 citationsEfficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups: ASCLEPIOS I/II Subgroup Analyses.Mitzi J Williams, Lilyana Amezcua, Stanley L Cohan, Jeffrey A Cohen, Silvia R Delgado
Neurology. 2024-08-13 - 8 citationsKey characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment.Silvia R Delgado, Simon Faissner, Ralf A Linker, Kottil Rammohan
Journal of Neurology. 2024-04-01
Journal Articles
- Numb Chin Syndrome secondary to Leptomeningeal Carcinomatosis from Gastric Adenocarcinoma.Riesgo V, Delgado S, Poveda J, Rammohan K., J Gastrointest Oncol 2015; 6(2):E16-E20. doi:10.3978/j.issn.2078-6891.2014.076., 1/1/2015
- CNS demyelinating disorder with mixed features of Neuromyelitis Optica and Multiple Sclerosis in HIV-1 infection. Case report and Literature review.Delgado S, Maldonado J, Rammohan K, J Neurovirol 2014; 20:531-537, 2014
- Focal Segmental Glomerulosclerosis secondary to subcutaneous Interferon β-1a treatment in a patient with Multiple Sclerosis.Tornes L, Delgado S, Garcia-Buitrago M, Ortega M, Rammohan, Multiple Sclerosis and Related Disorders 2012; 1 (3): 148-151., 1/1/2012
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: